Tech & devices

  • Design-led platform technologies tackling fertility and early childhood health

    By Laurent van Lerberghe, Founder and Managing Partner, KELES In my years working in life sciences investment, I’ve encountered brilliant minds developing next-generation medical technologies, from AI-driven therapeutics to advanced diagnostics. We now see these going one step further, delivering even greater impact on women’s and family health by integrating design with cutting-edge, AI-enabled science [...]

  • Free to Feed launches AI-powered allergy ally with Ema

    By Morgan Rose, CNM, WHNP-BC, IBCLC | Chief Science Officer, Ema In a bold stride toward reshaping paediatric allergy care, Free to Feed has launched a groundbreaking new partnership with Ema, the first AI platform built for women’s health. This collaboration is more than technology; it radically improves how we identify and support food-allergic children [...]

  • AI built for women, not just about women: Inside Ema’s groundbreaking pilot

    By Morgan Rose, CNM, WHNP-BC, IBCLC | Chief Science Officer, Ema AI is not a feature. It’s infrastructure. That’s the thesis behind Ema’s newly launched Women’s Health AI Pilot, a fully funded programme aimed at rethinking how intelligence is integrated, not bolted on, across care, wellness, and diagnostics. And it’s not hypothetical. Five companies will [...]

  • Interview: New horizons in endometriosis diagnosis

    Winner of the Femtech World Menstrual Health Innovation Award 2025, Serac Healthcare, is aiming to revolutionise endometriosis diagnosis via a non-invasive diagnostic molecular imaging agent. Serac Healthcare chief executive, David Hail, speaks to FemTech World about the company’s mission to improve diagnostic timelines for the condition and empower women’s health. Endometriosis affects more than 176 [...]

  • Simplifying complex women’s health issues with AI

    By Laurent van Lerberghe, managing partner at KELES I often ask myself if technology is the solution to solving complexities in women’s health. Women’s health has been a Cinderella area of research for some time, but increasing investment and technology innovation is changing the game, creating a vibrant ecosystem of companies offering exciting and innovative [...]

  • Mumbai’s Luma Fertility raises US$4m seed round

    A Mumbai-based fertility health-tech startup has raised US$4m in seed funding to expand its services across the city and into other parts of India. Luma Fertility will use the investment to expand its footprint in Mumbai and later scale into other cities over the next two years. The startup operates a 6,000-square-foot facility housing a [...]

  • Belfast startup launches AI period tracking tool

    A Belfast-based femtech company has launched what it claims is the world’s first AI-powered menstrual tracking system that provides clinical-grade insights into period volume, clotting and cycle trends. Joii’s technology, unveiled in Dublin, combines a specially designed menstrual pad with a mobile app to measure blood volume and clot size in millilitres – offering users [...]

  • Future Fertility unveils ROSE™, a new AI-based egg quality tool that aims to transform donor egg programs

    As demand for egg donation grows around the world, Future Fertility is bringing transparency, predictability, and reliability to donor oocyte programs. The company has announced the launch of ROSE—a new AI-powered oocyte quality workflow and report built specifically for egg banks and donor egg programs. Jullin Fjeldstad is Head of Clinical Embryology and Scientific Operations [...]

  • PCOS app targets insulin resistance in new approach

    An app focused on insulin resistance in polycystic ovary syndrome (PCOS) is launching this week, aiming to offer personalised tools for women managing the condition. Lilli Health says its Lilli App is the first comprehensive platform built specifically to address insulin resistance in PCOS – a hormone imbalance that affects up to 20 per cent [...]

  • Precision oncology is here — So why are so many breast cancer treatments still a gamble?

    By OncoGenomX, Allschwil, Switzerland When it comes to breast cancer treatment, one truth remains painfully clear: despite decades of progress we still cannot answer the question which treatment(s) a tumour will respond to. At OncoGenomX, we think it’s time to change that. We now have tools that allow us to look inside a tumour, understand [...]